Surmodics | SRDX - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Abbott USD 2.25B 73M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
Artivion USD 4.39M 2.12M 2024-09
Baxter International USD -214.2M 415.4M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
J&J USD 5.59B 1.81B 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Mesa Laboratories USD 5.78M 2.27M 2024-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Option Care Health USD 91.5M 6.99M 2025-12
Stryker USD 1.97B 609M 2025-12
Surmodics USD -5.64M 276K 2024-09
Trinity Biotech USD -509K 6.27M 2025-09